Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

SITAGLIPTIN FPH TABLETS 50MG - PPB Drug Approval Details

Approvals/PPB/SITAGLIPTIN FPH TABLETS 50MG

Approved

STANDARD

SITAGLIPTIN FPH TABLETS 50MG

fortune pharmacal co ltd🇰🇪 Pharmacy and Poisons Board

Approval Date: Jun 21, 2024
Approval ID: 22d521498d43f925
Company: fortune pharmacal co ltd
Type: Standard

Approval Details

Approval Id: 22d521498d43f925
Product Name: SITAGLIPTIN FPH TABLETS 50MG
Drug Hk Name: SITAGLIPTIN FPH TABLETS 50MG
Registration Code: HK-68104
Company Name: fortune pharmacal co ltd
Registration Category: Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement: Prescription only Medicines
Registration Date: 2024-01-12
Company Address: 5/F SAFETY GODOWN IND BLDG, 56 KA YIP ST. CHAI WAN HK

Active Ingredients

Approved

Quick Info

Agency

PPB

Country

🇰🇪

Approval Date

Jun 21, 2024

Approval ID

22d521498d43f925

Type

Standard

Back to PPB Approvals